"Some of the most promising emergent biopharmaceuticals for cancer therapy include agents capable of selective homing to the tumor environment, as well as drugs capable of selective activation of the immune system against malignant cells."

Dario Neri, Ph.D., Swiss Federal Institute of Technology

"You have put together an amazing meeting."

Sergio A. Quezada, Ph.D., UCL Cancer Institute